San Francisco, Ca: Drug and Alcohol Rehabilitation Center Southern California
San Francisco, Ca: Drug and Alcohol Rehabilitation Center Southern California – Laguna Beach Recovery Center www.Lagunarecovery.com (866)491-0214 Laguna Beach Recovery Center is based on a loving dignified approach, in renowned Laguna Beach, California. As an Alcohol and drug treatment recovery facility we have the highest long-term success rate in the industry, and will treat you or your loved one like family. We have a highly effective therapeutic approach to treating alcohol and drug addiction. Our renowned treatment is coupled with our finely appointed amenities that are steps from the beach. We focus on providing the foundation and tools for lifelong recovery. Each program is designed and based upon an individuals specific needs. We have a wide variety of programs including 3-5 day detox, 7-10 day fast track, core 30 day programs, extended care, transitional living, as well as executive and professional treatment options.
Titan Pharmaceuticals Announces Submission of New Drug Application for …
Filed under: drug treatment programs in san francisco
SOUTH SAN FRANCISCO, CA, Oct 29, 2012 (MARKETWIRE via COMTEX) — Titan Pharmaceuticals, Inc. (TTNP) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the investigational product Probuphine …
Read more on MarketWatch (press release)
Aegerion Shares Rise on Report of High Cholesterol Drug
Filed under: drug treatment programs in san francisco
The once-daily pill aims to treat a genetic condition known as familial hypercholesterolemia that causes abnormalities in liver cells responsible for clearing LDL, or low density lipoprotein, particles from the blood. The disease can lead to heart …
Read more on Businessweek
FDA Approves Expanded Indication for ACTEMRA® in Rheumatoid Arthritis
Filed under: drug treatment programs in san francisco
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA® (tocilizumab …
Read more on DailyFinance